These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32735823)

  • 21. Pharmacological Rescue of Hippocampal Fear Learning Deficits in Fragile X Syndrome.
    Martinez LA; Tejada-Simon MV
    Mol Neurobiol; 2018 Jul; 55(7):5951-5961. PubMed ID: 29128904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic minocycline treatment improves hippocampal neuronal structure, NMDA receptor function, and memory processing in Fmr1 knockout mice.
    Yau SY; Bettio L; Vetrici M; Truesdell A; Chiu C; Chiu J; Truesdell E; Christie BR
    Neurobiol Dis; 2018 May; 113():11-22. PubMed ID: 29367010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fragile-X Syndrome Is Associated With NMDA Receptor Hypofunction and Reduced Dendritic Complexity in Mature Dentate Granule Cells.
    Yau SY; Bettio L; Chiu J; Chiu C; Christie BR
    Front Mol Neurosci; 2018; 11():495. PubMed ID: 30705620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model.
    Bilousova TV; Dansie L; Ngo M; Aye J; Charles JR; Ethell DW; Ethell IM
    J Med Genet; 2009 Feb; 46(2):94-102. PubMed ID: 18835858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Voluntary Exercise on Cell Proliferation and Neurogenesis in the Dentate Gyrus of Adult FMR1 Knockout Mice.
    Pinar C; Yau SY; Sharp Z; Shamei A; Fontaine CJ; Meconi AL; Lottenberg CP; Christie BR
    Brain Plast; 2018 Dec; 4(2):185-195. PubMed ID: 30598869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of BDNF expression in Fmr1 knockout mice worsens cognitive deficits but improves hyperactivity and sensorimotor deficits.
    Uutela M; Lindholm J; Louhivuori V; Wei H; Louhivuori LM; Pertovaara A; Akerman K; Castrén E; Castrén ML
    Genes Brain Behav; 2012 Jul; 11(5):513-23. PubMed ID: 22435671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of GSK3β improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome.
    Guo W; Murthy AC; Zhang L; Johnson EB; Schaller EG; Allan AM; Zhao X
    Hum Mol Genet; 2012 Feb; 21(3):681-91. PubMed ID: 22048960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Voltage-Independent SK-Channel Dysfunction Causes Neuronal Hyperexcitability in the Hippocampus of
    Deng PY; Carlin D; Oh YM; Myrick LK; Warren ST; Cavalli V; Klyachko VA
    J Neurosci; 2019 Jan; 39(1):28-43. PubMed ID: 30389838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal neuronal morphology and neurochemistry in the auditory brainstem of Fmr1 knockout rats.
    Ruby K; Falvey K; Kulesza RJ
    Neuroscience; 2015 Sep; 303():285-98. PubMed ID: 26166728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circuit-based intervention corrects excessive dentate gyrus output in the fragile X mouse model.
    Deng PY; Kumar A; Cavalli V; Klyachko VA
    Elife; 2024 Feb; 12():. PubMed ID: 38345852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal of ultrasonic vocalization deficits in a mouse model of Fragile X Syndrome with minocycline treatment or genetic reduction of MMP-9.
    Toledo MA; Wen TH; Binder DK; Ethell IM; Razak KA
    Behav Brain Res; 2019 Oct; 372():112068. PubMed ID: 31271818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hippocampal dysfunction and cognitive impairment in Fragile-X Syndrome.
    Bostrom C; Yau SY; Majaess N; Vetrici M; Gil-Mohapel J; Christie BR
    Neurosci Biobehav Rev; 2016 Sep; 68():563-574. PubMed ID: 27345143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice.
    Michalon A; Bruns A; Risterucci C; Honer M; Ballard TM; Ozmen L; Jaeschke G; Wettstein JG; von Kienlin M; Künnecke B; Lindemann L
    Biol Psychiatry; 2014 Feb; 75(3):189-97. PubMed ID: 23910948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Astrocytic Contributions to Synaptic and Learning Abnormalities in a Mouse Model of Fragile X Syndrome.
    Hodges JL; Yu X; Gilmore A; Bennett H; Tjia M; Perna JF; Chen CC; Li X; Lu J; Zuo Y
    Biol Psychiatry; 2017 Jul; 82(2):139-149. PubMed ID: 27865451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein synthesis levels are increased in a subset of individuals with fragile X syndrome.
    Jacquemont S; Pacini L; Jønch AE; Cencelli G; Rozenberg I; He Y; D'Andrea L; Pedini G; Eldeeb M; Willemsen R; Gasparini F; Tassone F; Hagerman R; Gomez-Mancilla B; Bagni C
    Hum Mol Genet; 2018 Jun; 27(12):2039-2051. PubMed ID: 29590342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adult Fmr1 knockout mice present with deficiencies in hippocampal interleukin-6 and tumor necrosis factor-α expression.
    Hodges SL; Nolan SO; Taube JH; Lugo JN
    Neuroreport; 2017 Dec; 28(18):1246-1249. PubMed ID: 28915148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired hippocampal representation of place in the Fmr1-knockout mouse model of fragile X syndrome.
    Arbab T; Pennartz CMA; Battaglia FP
    Sci Rep; 2018 Jun; 8(1):8889. PubMed ID: 29892074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal hippocampal theta and gamma hypersynchrony produces network and spike timing disturbances in the Fmr1-KO mouse model of Fragile X syndrome.
    Arbab T; Battaglia FP; Pennartz CMA; Bosman CA
    Neurobiol Dis; 2018 Jun; 114():65-73. PubMed ID: 29486296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective memory engram reactivation underlies impaired fear memory recall in Fragile X syndrome.
    Li J; Jiang RY; Arendt KL; Hsu YT; Zhai SR; Chen L
    Elife; 2020 Nov; 9():. PubMed ID: 33215988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. STEP inhibition reverses behavioral, electrophysiologic, and synaptic abnormalities in Fmr1 KO mice.
    Chatterjee M; Kurup PK; Lundbye CJ; Hugger Toft AK; Kwon J; Benedict J; Kamceva M; Banke TG; Lombroso PJ
    Neuropharmacology; 2018 Jan; 128():43-53. PubMed ID: 28943283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.